Pessimistic
Last updated: 2026-08-23 08:34:49 ET
Decade-long study finds stark gender difference in outcomes of people with heart diseaseMillions of men with heart disease have a higher risk of devel...
Chester zoo resident, 23, ‘back to her usual feisty self’ after electrochemotherapy for tumour in her jawA 15ft (4.5-metre) python is believed to ...
Doctors and patients are excited about the possible breakthrough, but some analysts believe there’s too much hype.
I spent decades pleasing everyone. Then cancer changed the equation.
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
A new jab extended the length of time patients were cancer free, but it is unclear for how long.
CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big win for mRNA vaccines ag...
Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, joins "The Takeout" to discuss the Trump administration's touting of l...
The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE